We need you - help us beat Dupuytren's disease!
We are working hard to discover a treatment for early stage Dupuytren's disease.
Currently, there is no approved treatment for early stage Dupuytren's disease. Instead, patients are left to watch their hands deteriorate until it is time to have corrective surgery. Data from our lab show that anti-TNF - a drug used to treat other inflammatory conditions - works on diseased tissue from patients with Dupuytren's disease.
Based on a positive signal from the first part of our study, we are now working on the next stage of our research: a randomised trial of anti-TNF treatment for early stage Dupuytren's disease.
NEWS: We've won an award!
We are delighted to have been chosen as the winner of the International Dupuytren Award 2019 for our publication of the results of part 1 of the RIDD trial
https://www.dupuytren-online.info/dupuytren_award.html
We are working to shape the medical care of early stage Dupuytren's disease. Our research focuses on finding the first targeted therapy involving a simple injection for patients with the condition that will preserve hand function and avoid the need for subsequent more invasive treatments such as surgery.
Our research study called RIDD is a major part of this work. [Learn more]
Learn about our work.
Spread our message.
Thank you!
02 May2019
We've won the International Dupuytren Award 2019!
We are delighted to have been chosen as the winner of the International Dupuytren Award 2019 for our publication of the results of part 1 of the RIDD trial.
